blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2663186

EP2663186 - LIPID-LOWERING ANTIDIABETIC AGENT [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  21.04.2017
Database last updated on 28.05.2024
FormerExamination is in progress
Status updated on  09.01.2017
Most recent event   Tooltip21.04.2017Application deemed to be withdrawnpublished on 24.05.2017  [2017/21]
Applicant(s)For all designated states
Thetis Pharmaceuticals LLC
167 Old Post Road
Southport, Connecticut 06890 / US
[2013/47]
Inventor(s)01 / MYLARI, Banavara L.
16617 Ashton Green Drive
Lutz Florida 33558 / US
02 / SCIAVOLINO, Frank C.
51 Oswegatchie Road
Waterford Connecticut 06385 / US
 [2013/47]
Representative(s)Crump, Julian Richard John, et al
Beresford Crump LLP
16 High Holborn
London WC1V 6BX / GB
[N/P]
Former [2014/27]Mintz Levin Cohn Ferris Glovsky and Popeo LLP
Alder Castle
10 Noble Street
London EC2V 7JX / GB
Former [2013/47]Geary, Stephen
Bawden & Associates 4 The Gatehouse 2 High Street Harpenden
Hertfordshire AL5 2TH / GB
Application number, filing date12734013.112.01.2012
WO2012US21070
Priority number, dateUS201161461113P12.01.2011         Original published format: US 201161461113 P
US20121334826511.01.2012         Original published format: US201213348265
[2013/47]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012097144
Date:19.07.2012
Language:EN
[2012/29]
Type: A1 Application with search report 
No.:EP2663186
Date:20.11.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 19.07.2012 takes the place of the publication of the European patent application.
[2013/47]
Search report(s)International search report - published on:US19.07.2012
(Supplementary) European search report - dispatched on:EP25.08.2014
ClassificationIPC:A61K31/155, C07C279/26, C07C279/04, C07C57/03, A61K31/202, A61P3/10
[2014/39]
CPC:
A61K31/155 (EP,KR,US); C07C279/04 (US); A01N37/52 (KR);
A61K31/202 (KR,US); A61P3/04 (EP); A61P3/06 (EP);
A61P3/10 (EP); A61P7/00 (EP); A61P9/00 (EP);
A61P9/06 (EP); A61P9/10 (EP); C07C251/08 (KR);
C07C279/26 (EP,US); C07C57/03 (US) (-)
Former IPC [2013/47]A01N37/52, A61K31/155
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/47]
TitleGerman:LIPIDSENKENDE ANTIDIABETESMITTEL[2013/47]
English:LIPID-LOWERING ANTIDIABETIC AGENT[2013/47]
French:AGENT ANTIDIABÉTIQUE ABAISSANT LE NIVEAU LIPIDIQUE[2013/47]
Entry into regional phase11.07.2013National basic fee paid 
11.07.2013Search fee paid 
11.07.2013Designation fee(s) paid 
11.07.2013Examination fee paid 
Examination procedure11.07.2013Examination requested  [2013/47]
23.03.2015Amendment by applicant (claims and/or description)
25.07.2016Despatch of a communication from the examining division (Time limit: M04)
06.12.2016Application deemed to be withdrawn, date of legal effect  [2017/21]
10.01.2017Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2017/21]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  25.07.2016
Fees paidRenewal fee
27.01.2014Renewal fee patent year 03
27.01.2015Renewal fee patent year 04
27.01.2016Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.01.201706   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO2005041923  (ALZA CORP [US], et al) [X] 1-15* paragraphs [0074] , [0075]; claims 4,16 *;
 [X]WO2010127099  (AMARIN CORP PLC [IE], et al) [X] 1-15 * paragraphs [0012] , [0023]; claims 3,33,34 *
International search[Y]US2006159746  (TROUP JOHN P [US], et al);
 [Y]US2008260819  (FLEMING ALISON B [US], et al);
 [Y]US2009054513  (WEBSTER GREGORY D [US], et al);
 [Y]US2010105773  (SMITH LOIS [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.